TrialPeerJ2022

Identification and validation of a ferroptosis-related lncRNA signature to robustly predict the prognosis, immune microenvironment, and immunotherapy efficiency in patients with clear cell renal cell carcinoma.

Lincheng Ju et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.